FIELD: pharmacology.
SUBSTANCE: invention relates to the field of pharmacology, namely to the use of the carrageenan:echinochrome A complex at a weight ratio of components of 10:1 as an antiviral agent against herpes simplex virus type 1.
EFFECT: invention provides expansion of the arsenal of agents having antiviral activity against herpes simplex virus type 1; use of the complex increases the resistance of cells to infection, has a direct effect on viral particles, reducing their ability to infect cells, suppresses the early stages of virus replication, i.e. provides preventive action, virucidal action and virus-inhibiting action; the calculated value of the selectivity index of the complex indicates the greater safety of its practical application.
1 cl, 1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL COMPOSITION | 2018 |
|
RU2697886C1 |
| AGENT POSSESSING ANTIVIRAL ACTION AGAINST TICK-BORNE ENCEPHALITIS VIRUSES AND HERPES SIMPLEX TYPE I | 2018 |
|
RU2697887C1 |
| ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
| AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
| MEANS FOR FORMATION OF MEDICINE FOR CURING TICK-BORNE ENCEPHALITIS | 2016 |
|
RU2651777C1 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| 2-AMINO-5,6-DIFLUOR-1-(BETA-D-RIBOFURANOSYL)-BENZIMIDAZOLE, METHOD FOR PRODUCTION AND ANTIVIRAL ACTIVITY IN TERMS OF HERPES SIMPLEX VIRUS TYPE I | 2016 |
|
RU2629670C2 |
| -4-[6-(PURINE-6-YLAMINO)HEXANOYL]-3,4-DIHYDRO-3-METHYL-7,8-DIFLUOR-2H-[1,4]BENZOXAZINE AND (3R)-4-[6-(PURINE-6-YLAMINO)HEXANOYL]-3,4-DIHYDRO-3-METHYL-7,8-DIFLUOR-2H-[1,4]BENZOXAZINE WITH ANTIVIRAL ACTIVITY | 2016 |
|
RU2644351C1 |
| ADJUVANT | 2020 |
|
RU2736933C1 |
| 2-[5-(4-METHOXY)-3-PHENYL-5,6-DIHYDRO-4H-[1,2,4,5]TETRAZIN-1-YL]-BENZOTHIAZOLES WITH ANTIVIRAL ACTIVITY AGAINST COXSACKIE B3 VIRUSES | 2022 |
|
RU2783659C1 |
